Top Key Companies for Monogenic Disease Testing Market: Celera Support Services, Abbott, ELITech Group, Auto Genomics, PerkinElmer, Bio-Rad Laboratories.
Monogenic Disease Testing Is Expected to Grow at A Significant Growth Rate, And the Forecast Period Is 2024-2032, Considering the Base Year As 2023.
Global Monogenic Disease Testing Market Overview And Scope:
The Global Monogenic Disease Testing Market Report 2024 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Monogenic Disease Testing utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2023 and 2030. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
This Market Research Report provides a comprehensive analysis of the global Monogenic Disease Testing Market and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Monogenic Disease Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Monogenic Disease Testing market.
Global Monogenic Disease Testing Market Segmentation
By Type, Monogenic Disease Testing market has been segmented into:
Carrier Testing
Diagnostic Testing
New-Born Screening
Predictive and Pre-Symptomatic Testing
Prenatal Testing
By Application, Monogenic Disease Testing market has been segmented into:
Hospitals
Clinics
Others
Regional Analysis of Monogenic Disease Testing Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Monogenic Disease Testing Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Monogenic Disease Testing market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Monogenic Disease Testing market.
Top Key Companies Covered in Monogenic Disease Testing market are:
Celera Support Services
Abbott
ELITech Group
Auto Genomics
PerkinElmer
Bio-Rad Laboratories
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Monogenic Disease Testing Market by Type
4.1 Monogenic Disease Testing Market Snapshot and Growth Engine
4.2 Monogenic Disease Testing Market Overview
4.3 Carrier Testing
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Carrier Testing: Geographic Segmentation Analysis
4.4 Diagnostic Testing
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Diagnostic Testing: Geographic Segmentation Analysis
4.5 New-Born Screening
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 New-Born Screening: Geographic Segmentation Analysis
4.6 Predictive and Pre-Symptomatic Testing
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Predictive and Pre-Symptomatic Testing: Geographic Segmentation Analysis
4.7 Prenatal Testing
4.7.1 Introduction and Market Overview
4.7.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.7.3 Key Market Trends, Growth Factors and Opportunities
4.7.4 Prenatal Testing: Geographic Segmentation Analysis
Chapter 5: Monogenic Disease Testing Market by Application
5.1 Monogenic Disease Testing Market Snapshot and Growth Engine
5.2 Monogenic Disease Testing Market Overview
5.3 Hospitals
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Hospitals: Geographic Segmentation Analysis
5.4 Clinics
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Clinics: Geographic Segmentation Analysis
5.5 Others
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Others: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Monogenic Disease Testing Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 CELERA SUPPORT SERVICES
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 ABBOTT
6.4 ELITECH GROUP
6.5 AUTO GENOMICS
6.6 PERKINELMER
6.7 BIO-RAD LABORATORIES
Chapter 7: Global Monogenic Disease Testing Market By Region
7.1 Overview
7.2. North America Monogenic Disease Testing Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 Carrier Testing
7.2.4.2 Diagnostic Testing
7.2.4.3 New-Born Screening
7.2.4.4 Predictive and Pre-Symptomatic Testing
7.2.4.5 Prenatal Testing
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Hospitals
7.2.5.2 Clinics
7.2.5.3 Others
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Monogenic Disease Testing Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 Carrier Testing
7.3.4.2 Diagnostic Testing
7.3.4.3 New-Born Screening
7.3.4.4 Predictive and Pre-Symptomatic Testing
7.3.4.5 Prenatal Testing
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Hospitals
7.3.5.2 Clinics
7.3.5.3 Others
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Monogenic Disease Testing Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 Carrier Testing
7.4.4.2 Diagnostic Testing
7.4.4.3 New-Born Screening
7.4.4.4 Predictive and Pre-Symptomatic Testing
7.4.4.5 Prenatal Testing
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Hospitals
7.4.5.2 Clinics
7.4.5.3 Others
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Monogenic Disease Testing Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 Carrier Testing
7.5.4.2 Diagnostic Testing
7.5.4.3 New-Born Screening
7.5.4.4 Predictive and Pre-Symptomatic Testing
7.5.4.5 Prenatal Testing
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Hospitals
7.5.5.2 Clinics
7.5.5.3 Others
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Monogenic Disease Testing Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 Carrier Testing
7.6.4.2 Diagnostic Testing
7.6.4.3 New-Born Screening
7.6.4.4 Predictive and Pre-Symptomatic Testing
7.6.4.5 Prenatal Testing
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Hospitals
7.6.5.2 Clinics
7.6.5.3 Others
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Monogenic Disease Testing Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 Carrier Testing
7.7.4.2 Diagnostic Testing
7.7.4.3 New-Born Screening
7.7.4.4 Predictive and Pre-Symptomatic Testing
7.7.4.5 Prenatal Testing
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Hospitals
7.7.5.2 Clinics
7.7.5.3 Others
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Monogenic Disease Testing Scope:
|
Report Data
|
Monogenic Disease Testing Market
|
|
Monogenic Disease Testing Market Size in 2022
|
USD XXX million
|
|
Monogenic Disease Testing CAGR 2023 - 2030
|
XX%
|
|
Monogenic Disease Testing Base Year
|
2022
|
|
Monogenic Disease Testing Forecast Data
|
2023 - 2030
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Celera Support Services, Abbott, ELITech Group, Auto Genomics, PerkinElmer, Bio-Rad Laboratories.
|
|
Key Segments
|
By Type
Carrier Testing
Diagnostic Testing
New-Born Screening
Predictive and Pre-Symptomatic Testing
Prenatal Testing
By Applications
Hospitals
Clinics
Others
|
